Literature DB >> 12112198

Case-control study of estrogen receptor gene polymorphisms in Parkinson's disease.

Demetrius M Maraganore1, Matthew J Farrer, Shannon K McDonnell, Alexis Elbaz, Daniel J Schaid, John A Hardy, Walter A Rocca.   

Abstract

We investigated the association of Parkinson's disease (PD) with two estrogen receptor gene polymorphisms. In a sample of 319 unrelated PD cases and 196 control subjects including both men and women, we observed no association of PD with the estrogen receptor genotypes derived from XbaI and PvuII digests. Analyses restricted to women or to cases and controls of European origin yielded similar findings. Further analyses stratified by age at examination or by family history did not show associations. While exogenous and endogenous estrogen may modify the risk of PD in women, the two estrogen receptor gene polymorphisms considered here do not seem to contribute to PD susceptibility. Copyright 2001 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112198     DOI: 10.1002/mds.1253

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  6 in total

Review 1.  Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.

Authors:  Glenda E Gillies; Simon McArthur
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

2.  Variants in estrogen-related genes and risk of Parkinson's disease.

Authors:  Sun Ju Chung; Sebastian M Armasu; Joanna M Biernacka; Timothy G Lesnick; David N Rider; Julie M Cunningham; Demetrius M Maraganore
Journal:  Mov Disord       Date:  2011-04-05       Impact factor: 10.338

3.  Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women.

Authors:  N Palacios; M Weisskopf; K Simon; X Gao; M Schwarzschild; A Ascherio
Journal:  Parkinsonism Relat Disord       Date:  2010-03-20       Impact factor: 4.891

4.  Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson's disease: a meta-analysis.

Authors:  Zhan Gao; Hong-Juan Fu; Ju-Jun Xue; Zhi-Xuan Wu; Li-Bo Zhao
Journal:  Mol Biol Rep       Date:  2014-03-05       Impact factor: 2.316

5.  Male/Female differences in neuroprotection and neuromodulation of brain dopamine.

Authors:  Mélanie Bourque; Dean E Dluzen; Thérèse Di Paolo
Journal:  Front Endocrinol (Lausanne)       Date:  2011-09-30       Impact factor: 5.555

Review 6.  Sex differences in Parkinson's disease.

Authors:  Glenda E Gillies; Ilse S Pienaar; Shiv Vohra; Zahi Qamhawi
Journal:  Front Neuroendocrinol       Date:  2014-03-04       Impact factor: 8.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.